نتائج البحث - "Danny, Rischin"

1

351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009

المؤلفون: Ramona F. Swaby, Natalyn Hawk, Joy Yang Ge, Lisa Licitra, Barbara Burtness, Danny Rischin, Lilian Siu, Kevin J. Harrington, Ezra E.W. Cohen, Makoto Tahara, Jean-Pascal Machiels, Jan B. Vermorken, Le Quynh-Thu, Behzad Bidadi

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c753ac99b3c7826d764b9d7bd77c8926Test
https://doi.org/10.1136/jitc-2020-sitc2020.0351Test

2

P-94 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009

المؤلفون: Barbara Burtness, Ezra E.W. Cohen, Natalyn Hawk, Behzad Bidadi, Makoto Tahara, Jean-Pascal Machiels, Jan B. Vermorken, Ramona F. Swaby, Joy Yang Ge, Lisa Licitra, Lillian L. Siu, Danny Rischin, Le Quynh, Kevin J. Harrington

المصدر: Oral Oncology. 118:10-11

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Pembrolizumab, Immunotherapy, medicine.disease, Head and neck squamous-cell carcinoma, chemistry.chemical_compound, chemistry, Internal medicine, medicine, Oral Surgery, business, Lenvatinib

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1a68e19f676c6eb4ba83cbf72f9d6e0cTest
https://doi.org/10.1016/s1368-8375Test(21)00381-x

3

P-88 First-Line Pembrolizumab With or Without Lenvatinib in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 3 LEAP-010 Study

المؤلفون: Lillian L. Siu, Danny Rischin, Ramona F. Swaby, Lisa Licitra, Cecilia Pinheiro, Kevin J. Harrington, Barbara Burtness, Ezra E.W. Cohen, Makoto Tahara, Jean-Pascal Machiels, Chinyere E. Okpara, Ying Zhu

المصدر: Oral Oncology. 118:7-8

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, First line, Pembrolizumab, medicine.disease, Head and neck squamous-cell carcinoma, chemistry.chemical_compound, chemistry, Internal medicine, Medicine, Oral Surgery, Lenvatinib, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::35d6bd52229d3a0230aa372d24d3b746Test
https://doi.org/10.1016/s1368-8375Test(21)00375-4

4

Carboplatin dosing in the era of IDMS-creatinine; the Cockroft-Gault formula no longer provides a sufficiently accurate estimate of glomerular filtration rate for routine use in clinical care

المؤلفون: Mark Rosenthal, Orla McNally, Meir Lichtenstein, Alan Herschtal, James R. Whittle, Luke McLean, Jonathan Wayne Graham, Huda Ismail, Danny Rischin, Rodney J. Hicks, Anne Hamilton

المصدر: Gynecologic oncology. 157(3)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, Urology, Renal function, Subgroup analysis, Antineoplastic Agents, urologic and male genital diseases, Carboplatin, Excretion, 03 medical and health sciences, chemistry.chemical_compound, Young Adult, 0302 clinical medicine, Medicine, Humans, Dosing, reproductive and urinary physiology, Aged, Retrospective Studies, Aged, 80 and over, Creatinine, urogenital system, business.industry, Obstetrics and Gynecology, Retrospective cohort study, Gold standard (test), Middle Aged, female genital diseases and pregnancy complications, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, business, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6049f19355613d2e8d128424259f1392Test
https://pubmed.ncbi.nlm.nih.gov/32220419Test

5

973TiP LEAP-010: Phase III study of first-line pembrolizumab with or without lenvatinib in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

المؤلفون: Cecilia Pinheiro, Kevin J. Harrington, J-P. Machiels, Ying Zhu, Chinyere E. Okpara, Ramona F. Swaby, Barbara Burtness, Danny Rischin, Lisa Licitra, L.L. Siu, Ezra E.W. Cohen, Makoto Tahara

المصدر: Annals of Oncology. 31:S683-S684

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, First line, Hematology, Pembrolizumab, medicine.disease, Head and neck squamous-cell carcinoma, chemistry.chemical_compound, chemistry, Internal medicine, medicine, In patient, Lenvatinib, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::40c4a76967c3296fe5cd23519a0647c3Test
https://doi.org/10.1016/j.annonc.2020.08.1088Test

6

Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition

المؤلفون: Richard B. Pearson, Kurt Lackovic, Ronny Drapkin, Chris Mitchell, Carleen Cullinane, Walid J Azar, Danny Rischin, David D.L. Bowtell, Alison M. Karst, Dariush Etemadmoghadam, Franziska Lang, Diar Aziz, Linda Mileshkin, George Au-Yeung, Kate E. Jarman

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Cyclin E, Pyridinium Compounds, AKT2, Biology, Article, Cyclic N-Oxides, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Cell Line, Tumor, medicine, Humans, RNA, Small Interfering, Dinaciclib, Protein kinase B, PI3K/AKT/mTOR pathway, Oncogene Proteins, Ovarian Neoplasms, Cyclin-Dependent Kinase 2, Cyclin-dependent kinase 2, Indolizines, Cancer, Bridged Bicyclo Compounds, Heterocyclic, medicine.disease, Molecular biology, 3. Good health, Gene Expression Regulation, Neoplastic, Oncogene Protein v-akt, Cyclin E1, 030104 developmental biology, Oncology, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64bda99fd9ee78eac4bd54b56f89ad1cTest
https://doi.org/10.1158/1078-0432.ccr-16-0620Test

7

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)

المؤلفون: Annabell F. Leske, Julie Martyn, Tina C. Lavranos, David Espinoza, Dirkje W. Sommeijer, Jose Iglesias, Philip Beale, Elizabeth E. Doolin, Jeremy Simpson, Danny Rischin, Jeff C. Goh, Gabriel Kremmidiotis, Emma C. Rossi, Kristina Lindemann, Anneso S. Veillard, Martin R. Stockler, Michelle Margaret Vaughan, Meaghan Tenney

المساهمون: Oncology

المصدر: Cancer chemotherapy and pharmacology, 83(1), 97-105. Springer Verlag

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Neutropenia, Adenocarcinoma, Toxicology, Deoxycytidine, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), In patient, Adverse effect, Aged, Benzofurans, Pharmacology, Ovarian Neoplasms, business.industry, Middle Aged, medicine.disease, Prognosis, Gemcitabine, Organophosphates, Phase i study, Cystadenocarcinoma, Serous, Endometrial Neoplasms, Survival Rate, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Platinum sensitive, Female, Neoplasm Recurrence, Local, business, Ovarian cancer, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1505eabd827e65c42487a3157a87ae2bTest
https://pure.amc.nl/en/publications/phase-i-study-of-bnc105p-carboplatin-and-gemcitabine-in-partially-platinumsensitive-ovarian-cancer-patients-in-first-or-second-relapse-anzgog1103Test(bec4efc5-2158-432c-b127-5dc2abc25aa3).html

8

Phase III LEAP-010 study: first-line pembrolizumab with or without lenvatinib in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

المؤلفون: Ramona F. Swaby, Barbara Burtness, Lisa Licitra, Makoto Tahara, Jean-Pascal Machiels, Ezra E.W. Cohen, Danny Rischin, Lillian L. Siu, Cecilia Pinheiro, Kevin J. Harrington, Ying Zhu, Chooi Peng Lee

المصدر: Journal of Clinical Oncology. 38:TPS6589-TPS6589

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, First line, Pembrolizumab, medicine.disease, Head and neck squamous-cell carcinoma, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Internal medicine, medicine, Lenvatinib, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::66f0bdc94f2b9925e02a947c1d20c575Test
https://doi.org/10.1200/jco.2020.38.15_suppl.tps6589Test

9

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial

المؤلفون: Michael Penniment, Adam Stoneley, Chris Milross, Danny Rischin, Michael Poulsen, Marnie Collins, Gerald B Fogarty, Michael Collins, Madeleine King, Michael Veness Veness, Benedict Panizza, Andrew Macann, Lizbeth Kenny, June Corry, Mathias Bressel, Sandro V. Porceddu, Howard Liu, Stephen Cooper, Chris Wratten

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36(13)

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Carcinoma, medicine, Humans, 030223 otorhinolaryngology, Survival rate, Aged, Neoplasm Staging, Randomized Controlled Trials as Topic, Postoperative Care, business.industry, Hazard ratio, Area under the curve, Radiotherapy Dosage, Chemoradiotherapy, Middle Aged, medicine.disease, Surgery, Radiation therapy, Clinical trial, Survival Rate, Oncology, chemistry, Clinical Trials, Phase III as Topic, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Radiotherapy, Adjuvant, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4b9952791314d3bb3f569bcf357166bTest
https://pubmed.ncbi.nlm.nih.gov/30264261Test

10

The Clinical Impact of Hypoxia in Head and Neck Squamous Cell Carcinoma

المؤلفون: Quynh-Thu Le, Danny Rischin, Annette M. Lim

المصدر: Molecular Determinants of Head and Neck Cancer ISBN: 9783319787619

مصطلحات موضوعية: Tumor hypoxia, business.industry, medicine.medical_treatment, Tumor Oxygenation, Hypoxia (medical), medicine.disease, Head and neck squamous-cell carcinoma, Radiation therapy, chemistry.chemical_compound, chemistry, Cancer cell, medicine, Cancer research, Tirapazamine, medicine.symptom, business, FMISO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a4e14cce19ac038d45204403960bb203Test
https://doi.org/10.1007/978-3-319-78762-6_15Test

تنقيح النتائج